Focus


Focus on Targeted cancer therapies

We thank Genentech for their generous support, which has enabled us to make this collection of recently published articles freely available to the community for a period of six months.

Top

Editorial

Focus on Targeted cancer therapies

Keeping pace with cancer p1380

doi:10.1038/nm.3395


Top

Perspective

Focus on Targeted cancer therapies

Mechanisms of resistance to therapies targeting BRCA-mutant cancers pp1381 - 1388

Christopher J Lord & Alan Ashworth

doi:10.1038/nm.3369


Top

Reviews

Focus on Targeted cancer therapies

The quest to overcome resistance to EGFR-targeted therapies in cancer pp1389 - 1400

Curtis R Chong & Pasi A Jänne

doi:10.1038/nm.3388


Focus on Targeted cancer therapies

Tumor adaptation and resistance to RAF inhibitors pp1401 - 1409

Piro Lito, Neal Rosen & David B Solit

doi:10.1038/nm.3392


Focus on Targeted cancer therapies

Unraveling the therapeutic potential of the Hedgehog pathway in cancer pp1410 - 1422

Dereck Amakye, Zainab Jagani & Marion Dorsch

doi:10.1038/nm.3389


Focus on Targeted cancer therapies

Microenvironmental regulation of tumor progression and metastasis pp1423 - 1437

Daniela F Quail & Johanna A Joyce

doi:10.1038/nm.3394


Focus on Targeted cancer therapies

The epigenetics of epithelial-mesenchymal plasticity in cancer pp1438 - 1449

Wai Leong Tam & Robert A Weinberg

doi:10.1038/nm.3336


Focus on Targeted cancer therapies

Tumor metastasis: moving new biological insights into the clinic pp1450 - 1464

Liling Wan, Klaus Pantel & Yibin Kang

doi:10.1038/nm.3391


Top

Extra navigation

natureevents

ADVERTISEMENT